Explore how Sanofi leverages R&D and AI technologies to drive innovation and excellence in biopharmaceutical services, improving lives globally.

Analyze how new policies affect prescription drug availability and launch timings in the US compared to other OECD nations, with insights from RAND’s comprehensive report.

Discover the latest analysis on how the IRA may cause delays in drug launches, reduce subsequent indications, and limit evidence generation.

Explore how the IRA influences drug launch analytics, leading to delays, fewer indications, and reduced evidence generation in the pharmaceutical industry.

Understand the challenges and opportunities decentralized clinical trials present for small to midsize biotechnology and biopharmaceutical companies, and how to effectively navigate them for successful outcomes.

Explore key considerations and strategies for small to midsize biotechnology and biopharmaceutical companies navigating decentralized clinical trials to enhance efficiency and patient outcomes.

Delve into our comprehensive analysis of US cancer drug launch prices and their clinical efficacy, uncovering trends and insights essential for pharmaceutical success.

Explore the trends in US cancer drug launch prices and their clinical efficacy from 2008 to 2022, providing valuable insights for optimizing drug launch analytics in the pharmaceutical industry.

Explore the trends in US cancer drug launch prices and their clinical efficacy from 2008 to 2022, providing valuable insights for optimizing drug launch analytics in the pharmaceutical industry.